Establishes mandatory supplemental therapeutic services reimbursement for certain individuals receiving services through the office for people with developmental disabilities.
This bill would create a new section of the mental hygiene law requiring the Commissioner of the Office for People With Developmental Disabilities to authorize supplemental reimbursement for certain medically necessary therapeutic services when those services cannot be obtained within 21 days at existing state-established reimbursement rates. Covered services include counseling, psychotherapy, behavioral therapy, and other clinically appropriate interventions, including applied behavior analysis (ABA), provided by properly licensed or otherwise authorized providers.
To qualify, the service must be included in an approved plan of care or other authorized planning document, and the individual or representative must document reasonable efforts to secure the service at the standard rate. If approved, the commissioner must pay 75 percent of billed charges, subject to statutory minimum and maximum hourly reimbursement floors and caps for individual therapy, group therapy, and ABA services. The bill also requires annual CPI-U-based increases to those reimbursement amounts beginning in 2028, mandates a 15-business-day decision deadline, and allows approval by operation of law if the agency does not act in time.
The bill would add a new reimbursement mechanism to the mental hygiene law and a related fraud-control provision to the public health law. It would affect OPWDD service recipients, their families and authorized representatives, care managers, service coordinators, and licensed therapeutic providers by creating a pathway to obtain higher or supplemental payment when standard reimbursement rates do not secure timely access to needed care. It also requires coordination with the Department of Health to ensure Medicaid compliance, authorizes regulations and program-integrity rules, and directs annual public reporting on applications, approvals, denials, reimbursement amounts, and access outcomes.
The bill’s structure suggests a generally supportive intent toward improving access to therapeutic services for people with developmental disabilities, especially where low reimbursement rates may limit provider availability. Its mandatory timelines, automatic approval feature, and indexed reimbursement floors indicate a strong policy preference for faster access and more reliable provider participation. No committee transcript or recorded vote information was provided, so there is no direct evidence of formal support or opposition in the legislative record included here.
The main points of potential contention are cost, administrative burden, and the bill’s effect on existing reimbursement systems. The mandatory minimum payment floors, annual inflation adjustments, and automatic approval if the agency misses the deadline could raise concerns for state budget officials and program administrators. Providers and advocates may support the bill as a response to inadequate rates and access barriers, while fiscal or Medicaid compliance concerns may focus on whether the supplemental payments could conflict with existing methodologies, require significant oversight, or create incentives for overbilling despite the bill’s audit and fraud-monitoring provisions.